Liver Transplantation: Clinical Trials

13 trials for Liver Transplantation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 unknown. 13 Phase 2, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 213Unknown 13
Phase 33Unknown 3
Phase 12Unknown 2

Follow Liver Transplantation: new trials by email Literature Review of Liver Transplantation trials Research Report on Liver Transplantation

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Feasibility Study of Octreotide Infusion During Liver Transplant.
Octreotide Acetate, Placebo - Liver Transplantation, Renal Failure
Phase 2UnknownUniversity College, London302022-05-272023-05-03
Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantation
Ascorbic acid, 0.9% Saline solution - Liver Transplantation, Postreperfusion Syndrome
Phase 2UnknownHospital Universitario Ramon y Cajal702020-11-172023-03-03
Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
lenvatinib, Placebo - Hepatocellular Carcinoma, Portal Vein Tumor Thrombus
Phase 2 / Phase 3UnknownRenJi Hospital1082020-05-022020-03-24
Study to Assess the Effect of Intravenous Supplementation of Omega-3 Fatty Acids on Outcome of Recipients in Living Donor Liver Transplantation
Omega 3 fatty acid - Liver Transplantation
Phase 2UnknownInstitute of Liver and Biliary Sciences, India1242018-12-022019-07-23
Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantation
Tacrolimus, Tacrolimus (Tacrolimus elimination), Sirolimus - Liver Transplantation
Phase 2 / Phase 3UnknownSouthern Medical University, China1302018-05-012018-04-18
Post Static Cold Storage Normothermic Machine Liver Perfusion
Normothermic Machine Liver Perfusion - Liver Transplantation
Phase 1 / Phase 2UnknownUniversity of Oxford302017-05-012017-06-05
Therapeutic Strategy and the Role of Mesenchymal Stromal Cells for ABO Incompatible Liver Transplantation
Mesenchymal Stem Cells(MSCs) - Liver Transplantation
Phase 1 / Phase 2UnknownThird Affiliated Hospital, Sun Yat-Sen University152014-02-012016-03-11
CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation
delayed, low-dose CNI, BU-CNI, BU-Everolimus - Renal Impairment, Liver Transplantation
Phase 2 / Phase 3UnknownUniversity of Regensburg452011-06-012011-07-01
Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients
immunosuppression withdrawal, continue of taking immunosuppressant - Liver Transplantation
Phase 2UnknownThe Catholic University of Korea202010-07-012010-09-10
Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation
Basiliximab (Simulect), Myfortic, everolimus - Liver Transplantation, Chronic Renal Insufficiency
Phase 2UnknownArmin Goralczyk292010-01-012011-09-15
Effect of Rapamycin on Tolerance-related Biomarkers on Stable Liver Transplant Recipients
Sirolimus, Calcineurin inhibitor - Liver Transplantation
Phase 2UnknownHospital Clinic of Barcelona522009-11-012009-12-17
Assessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction of Operational Tolerance
Gradual immunosuppression drug withdrawal - Liver Transplantation
Phase 2UnknownHospital Clinic of Barcelona802005-11-012011-04-20
Prophylaxis With Caspofungin in High-Risk Liver Transplantation
Caspofungin - Liver Transplantation, Fungal Infection
Phase 2UnknownGrupo de Estudio de Infecciones en Transplantados702003-10-012007-04-13

Narrower conditions

Renal Insufficiency (3)  ·  Carcinoma, Hepatocellular (1)  ·  Invasive Fungal Infections (1)  ·  Mycoses (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Adenocarcinoma (1)  ·  Bacterial Infections and Mycoses (1)  ·  Carcinoma (1)  ·  Chronic Disease (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Disease Attributes (1)  ·  Infections (1)  ·  Liver Diseases (1)

Interventions

Mycophenolic Acid (2)  ·  Sirolimus (2)  ·  Ascorbic Acid (1)  ·  Basiliximab (1)  ·  Calcineurin Inhibitors (1)  ·  Caspofungin (1)  ·  Everolimus (1)  ·  Fatty Acids, Omega-3 (1)  ·  Octreotide (1)  ·  Prednisolone (1)  ·  Prednisone (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Tacrolimus (1)  ·  cni protein, Drosophila (1)

Sponsors

Hospital Clinic of Barcelona (2)  ·  Armin Goralczyk (1)  ·  Grupo de Estudio de Infecciones en Transplantados (1)  ·  Hospital Universitario Ramon y Cajal (1)  ·  Institute of Liver and Biliary Sciences, India (1)  ·  RenJi Hospital (1)  ·  Southern Medical University, China (1)  ·  The Catholic University of Korea (1)  ·  Third Affiliated Hospital, Sun Yat-Sen University (1)  ·  University College, London (1)  ·  University of Oxford (1)  ·  University of Regensburg (1)

Countries

Spain (4)  ·  China (2)  ·  Germany (2)  ·  United Kingdom (2)  ·  India (1)  ·  South Korea (1)

Top investigators

Aiman Obed, PD Dr. (1)  ·  Alberto Sanchez Fueyo, MD (1)  ·  Alberto Sanchez-Fueyo, MD (1)  ·  Andreas A Schnitzbauer, MD (1)  ·  Armin D Goralczyk, Dr. (1)  ·  Giuseppe Tisone, MD (1)  ·  Hans J Schlitt, MD (1)  ·  Jacques Pirenne, MD (1)  ·  Jesus Fortun, MD (1)  ·  Jong Young Choi, Professor (1)  ·  Kebo Zhong, M.D (1)  ·  Luis Gajate, MD PhD (1)  ·  Michael Spiro (1)  ·  Peter Friend (1)  ·  Viniyendra Pamecha, Professor (1)

Results publications

PMID 20380712, PMID 38100226, PMID 40719561, PMID 41128798, PMID 41500624